LISA ROSEBERRY: Open Payments
NPI 1588910129 · HAMPTON, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,233 in 38 payments from 5 companies in 2025. Trend: 2023 $442 · 2024 $907 · 2025 $1,233
Food & beverage: $1,229Education: $4
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $504 |
| Otsuka America Pharmaceutical, Inc. | 7 | $304 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $265 |
| ABBVIE INC. | 11 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: Auvelity, REXULTI, CAPLYTA, VRAYLAR, TRINTELLIX.
Industry payments across NH — which companies pay providers there.
